European Society for Organ Transplantation (ESOT) Consensus Statement on the Role of Pancreas Machine Perfusion to Increase the Donor Pool for Beta Cell Replacement Therapy - Inserm - Institut national de la santé et de la recherche médicale
Article Dans Une Revue Transplant International Année : 2023

European Society for Organ Transplantation (ESOT) Consensus Statement on the Role of Pancreas Machine Perfusion to Increase the Donor Pool for Beta Cell Replacement Therapy

1 Clinic Barcelona Hospital Universitari
2 BCLC - Barcelona Clínic Liver Cancer
3 IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
4 CIBERehd - Centro de Investigación Biomédica en Red en el Área temática de Enfermedades Hepáticas y Digestivas
5 U1064 Inserm - CR2TI - Centre de Recherche en Transplantation et Immunologie - Center for Research in Transplantation and Translational Immunology
6 Team 3 - U1064 Inserm - CR2TI - Team 3 : Integrative transplantation, HLA, Immunology and genomics of kidney injury
7 ITERT - Institut de Transplantation et de Recherche en Transplantation [CHU Nantes]
8 Département d'urologie et de chirurgie de transplantation [CHU Nantes]
9 Leopold Franzens Universität Innsbruck - University of Innsbruck
10 LUMC - Leiden University Medical Center
11 University of Maryland School of Medicine
12 UTMB - The University of Texas Medical Branch
13 UMCG - University Medical Center Groningen [Groningen]
14 Karolinska Institutet [Stockholm]
15 Hammersmith Hospital NHS Imperial College Healthcare
16 Nuffield Department of Surgical Sciences [Oxford, UK]
17 TGHRI - Toronto General Hospital Research Institute [Canada]
18 Newcastle University [Newcastle]
19 University of Pisa - Università di Pisa
20 HUG - Hôpitaux Universitaires de Genève
21 UNIGE - Université de Genève = University of Geneva
22 VUB - Vrije Universiteit Brussel [Bruxelles]
23 UZ Brussel - Universitair Ziekenhuis Brussel = University Hospital of Brussels
24 Guy's Hospital [London]

Résumé

The advent of Machine Perfusion (MP) as a superior form of preservation and assessment for cold storage of both high-risk kidney’s and the liver presents opportunities in the field of beta-cell replacement. It is yet unknown whether such techniques, when applied to the pancreas, can increase the pool of suitable donor organs as well as ameliorating the effects of ischemia incurred during the retrieval process. Recent experimental models of pancreatic MP appear promising. Applications of MP to the pancreas, needs refinement regarding perfusion protocols and organ viability assessment criteria. To address the “Role of pancreas machine perfusion to increase the donor pool for beta cell replacement,” the European Society for Organ Transplantation (ESOT) assembled a dedicated working group comprising of experts to review literature pertaining to the role of MP as a method of improving donor pancreas quality as well as quantity available for transplant, and to develop guidelines founded on evidence-based reviews in experimental and clinical settings. These were subsequently refined during the Consensus Conference when this took place in Prague.
Fichier principal
Vignette du fichier
ti-36-11374.pdf (935.72 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

inserm-04215161 , version 1 (22-09-2023)

Licence

Identifiants

Citer

Joana Ferrer-Fàbrega, Benoît Mesnard, Franka Messner, Jason Doppenberg, Cinthia Drachenberg, et al.. European Society for Organ Transplantation (ESOT) Consensus Statement on the Role of Pancreas Machine Perfusion to Increase the Donor Pool for Beta Cell Replacement Therapy. Transplant International, 2023, 36, pp.11374. ⟨10.3389/ti.2023.11374⟩. ⟨inserm-04215161⟩
10 Consultations
6 Téléchargements

Altmetric

Partager

More